Power Law company profile

Swixx Biopharma

Biotech & Life Sciences · Baar, Switzerland · Founded 2014 Unicorn

Expanding access to modern medicines across high-growth global markets

Valuation

$1–2.5B

Latest valuation · 2026

Unlock exact value

Revenue

$500M–1B

Latest reported FY

Unlock exact value

Headcount

1–2k

Current team size

Unlock exact value

Featured in Unicorn$1B+ valuation tier · Power Law dataset 2026 $10B+ revenueThoroughbred · Power Law outcome

Investors

2 investors on Swixx Biopharma's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage

HBM Healthcare Investments

Series B+ 1 investor entered at this stage

Mérieux Equity Partners

Global footprint

Where Swixx Biopharma has talent and traffic

Workforce by country

33 countries with
team presence

🇷🇸 Serbia15.6%

🇧🇬 Bulgaria10.5%

🇸🇮 Slovenia8.5%

🇭🇷 Croatia7.6%

🇨🇿 Czech Republic6.9%

Top 5 of 33 shown

Web traffic by country

4K monthly visits
across markets

🇺🇸 United States30%

🇮🇳 India20%

🇬🇧 United Kingdom17.5%

🏳️ Russian Federation12.5%

🇨🇭 Switzerland10%

Top 5 markets shown

Market sentiment

What the market is saying about Swixx Biopharma

An AI-synthesized read of the highest-engagement posts about Swixx Biopharma on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Swixx Biopharma on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles